These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3299565

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P, Rensch H.
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [Abstract] [Full Text] [Related]

  • 24. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
    Germouty J, Jirou-Najou JL.
    Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Multicenter study on the treatment of secretory otitis media with ambroxol. Importance of a surface-tension-lowering substance.
    Passàli D, Zavattini G.
    Respiration; 1987; 51 Suppl 1():52-9. PubMed ID: 3602599
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ambroxol decreases bronchial hyperreactivity.
    Melillo G, Cocco G.
    Eur J Respir Dis; 1986 Nov; 69(5):316-20. PubMed ID: 3539631
    [Abstract] [Full Text] [Related]

  • 29. [Induction of fetal lung maturation using ambroxol and betamethasone. Results of an open multicenter study].
    Wolff F, Ponnath H, Wiest W.
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):19-25. PubMed ID: 3552853
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of secretory otitis media with ambroxol].
    Sartoris A.
    Acta Otorhinolaryngol Ital; 1987 Jan; 7 Suppl 16():51-60. PubMed ID: 3334304
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effect on the mucociliary clearance of ambroxol administered via inhalation: preliminary observations].
    Olivieri D, Del Donno M, Annicelli A, Palmieri F.
    Arch Monaldi; 1983 Jan; 38(4):135-40. PubMed ID: 6679252
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A controlled trial of bromhexine ('Bisolvon') in out-patients with chronic bronchitis.
    Lal S, Bhalla KK.
    Curr Med Res Opin; 1975 Jan; 3(2):63-7. PubMed ID: 1095307
    [Abstract] [Full Text] [Related]

  • 37. [Ambroxol in bronchopulmonary pathology in children].
    Berni M, Collina A, Zavattini G.
    Clin Ter; 1983 Sep 15; 106(5):351-5. PubMed ID: 6641103
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Ambroxol versus betamethasone for stimulating antepartal lung maturity--a multicenter study].
    Salzer H, Weidinger H, Simbruner G, Vytiska-Binstorfer E.
    Z Geburtshilfe Perinatol; 1986 Sep 15; 190(1):49-59. PubMed ID: 3515786
    [Abstract] [Full Text] [Related]

  • 40. Effects of a beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with COLD.
    Weiss T, Dorow P, Felix R.
    Chest; 1981 Dec 15; 80(6 Suppl):881-5. PubMed ID: 7030660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.